News
The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative.
Hosted on MSN15d
Spring’s Greatest Fails - MSNSpring has sprung—and so have the fails! From backyard bloopers to egg hunts gone wrong, this seasonal special features the best fails of spring.
Saia doesn’t provide any revenue-based metrics in its intraquarter updates. During the first quarter, yields were negative (down 5.1% y/y excluding fuel surcharges). Heavier shipment weights were a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results